Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

21.87 

0.81 3.9%

as of Apr 09 '21

52 Week Range:

16.20 29.02


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil and mechanical engineering, industrial engineering, dentistry, pedagogy, nutrition, physiotherapy, psychology, architecture, veterinary medicine, and others. In addition, the company provides distance learning residency preparatory courses through its online platform; and develops and sells printed and digital medical education content. As of December 31, 2019, it operated a network of 19 undergraduate and graduate medical school campuses consisted of 12 operating units and seven approved units. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 5.56
growth rate
Earnings BIT 49.34
96.45
207.80
363.34
growth rate 95.5% 115.5% 74.9%
ROA 43.81
16.90
8.04
growth rate -61.4% -52.4%
ROE 98.44
31.51
11.99
growth rate -68.0% -62.0%
ROIC 86.85
26.83
13.13
growth rate -69.1% -51.1%
Cur. Ratio 1.16
0.73
3.34
growth rate -37.1% 357.5%
Quick Ratio 1.12
0.67
3.23
growth rate -40.2% 382.1%
Leverage 2.25
1.83
1.41
growth rate -18.7% -23.0%
Balance Sheet Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 32.74
60.71
131.92
323.34
growth rate 85.4% 117.3% 145.1%
Acct.Payable 6.74
8.10
17.63
35.74
growth rate 20.3% 117.5% 102.8%
Cur.Assets 60.48
133.50
1,111.77
1,405.50
growth rate 120.7% 732.8% 26.4%
Total Assets 103.63
918.42
2,912.45
4,793.09
growth rate 786.3% 217.1% 64.6%
Cash 25.49
62.26
943.21
1,045.04
growth rate 144.3% 1,415.0% 10.8%
Inventory 0.45
1.12
3.93
7.51
growth rate 148.9% 252.7% 91.0%
Cur.Liabilities 51.94
182.33
333.23
589.38
growth rate 251.0% 82.8% 76.9%
Liabilities 56.86
328.06
798.73
1,959.31
growth rate 476.9% 143.5% 145.3%
LT Debt 2.77
51.03
6.75
576.00
growth rate 1,743.5% -86.8% 8,433.4%
Equity 46.11
501.98
2,065.09
2,782.22
growth rate 988.6% 311.4% 34.7%
Common Shares 88.00
88.00
76.00
0.02
growth rate 0.0% -13.6% -100.0%
Cash Flow Statement Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 16.78
18.63
56.96
89.83
growth rate 11.1% 205.7% 57.7%
Cash Dividends 38.00
38.00
38.00
growth rate 0.0% 0.0%
Cash From OA 39.92
80.32
299.22
371.51
growth rate 101.2% 272.5% 24.2%
FCF per Share 0.38
growth rate
FCF 19.00
59.00
178.00
281.68
growth rate 210.5% 201.7% 58.2%
Income Statement Dec '17 Dec '18 Dec '19 Dec '20
Sales 216.01
333.94
750.63
1,201.19
growth rate 54.6% 124.8% 60.0%
Op.Income 49.34
96.45
207.80
363.34
growth rate 95.5% 115.5% 74.9%
IBT 50.98
98.72
186.94
335.05
growth rate 93.7% 89.4% 79.2%
Net Income 45.39
86.35
153.92
292.08
growth rate 90.2% 78.2% 89.8%
EPS 0.52
0.98
2.02
growth rate 88.5% 106.1%
Gross Profit 91.94
165.88
441.78
766.54
growth rate 80.4% 166.3% 73.5%
R&D 0.00 0.00
growth rate

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 77.71
96.27
78.47
95.01
92.21
growth rate 23.9% -18.5% 21.1% -3.0%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 131.92
167.41
257.65
255.65
323.34
growth rate 26.9% 53.9% -0.8% 26.5%
Acct.Payable 17.63
22.85
23.23
32.45
35.74
growth rate 29.6% 1.7% 39.7% 10.1%
Cur.Assets 1,111.77
1,499.46
1,338.22
1,369.77
1,405.50
growth rate 34.9% -10.8% 2.4% 2.6%
Total Assets 2,912.45
3,602.13
3,850.19
4,047.82
4,793.09
growth rate 23.7% 6.9% 5.1% 18.4%
Cash 943.21
1,283.11
1,041.46
1,065.23
1,045.04
growth rate 36.0% -18.8% 2.3% -1.9%
Inventory 3.93
5.58
5.38
5.84
7.51
growth rate 41.9% -3.7% 8.6% 28.7%
Cur.Liabilities 333.23
400.07
462.53
572.45
589.38
growth rate 20.1% 15.6% 23.8% 3.0%
Liabilities 847.36
1,008.43
1,190.62
1,283.94
1,959.31
growth rate 19.0% 18.1% 7.8% 52.6%
LT Debt 6.75
16.72
88.42
84.16
576.00
growth rate 147.8% 428.7% -4.8% 584.4%
Equity 2,065.09
2,542.82
2,609.65
2,712.07
2,782.22
growth rate 23.1% 2.6% 3.9% 2.6%
Common Shares 89.74
0.02
0.02
0.02
0.02
growth rate -100.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 20.38
17.68
19.91
23.30
28.95
growth rate -13.3% 12.6% 17.1% 24.2%
Cash Dividends 0.00
growth rate
Cash From OA 68.57
101.40
88.02
119.50
62.59
growth rate 47.9% -13.2% 35.8% -47.6%
FCF 48.19
83.72
68.11
96.20
33.65
growth rate 73.7% -18.6% 41.2% -65.0%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 220.85
272.30
274.21
309.41
345.27
growth rate 23.3% 0.7% 12.8% 11.6%
Op.Income 53.85
96.27
78.47
95.01
92.21
growth rate 78.8% -18.5% 21.1% -3.0%
IBT 57.45
109.73
70.23
84.27
70.84
growth rate 91.0% -36.0% 20.0% -15.9%
Net Income 49.80
99.82
60.68
74.83
56.75
growth rate 100.5% -39.2% 23.3% -24.2%
Gross Profit 135.99
183.05
167.53
197.12
218.84
growth rate 34.6% -8.5% 17.7% 11.0%
R&D 0.00
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (100.00)

YOY Growth Grade:

A+ (100.00)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is undefined, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 4.98
EPS / Growth 10.4%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 50.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.4% 30.2% 55.2%
Future PE 0.01 3.33 38.45
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT

Graham Number:

Current EPS is undefined, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.